What can you say
Can you use patient testimonials in addiction treatment marketing?
Two federal walls, one state trap, and the paperwork that is the whole point.
Rarely, and never casually. A recovery testimonial hits two federal rules at once: 42 CFR Part 2, which protects the identity of anyone who sought SUD treatment, and the FTC endorsement rules. Some states ban physician testimonials outright. It is possible with Part 2 written consent and disclosures, but the safe default is no.
42 CFR Part 2 protects the identity of anyone who applied for or received substance use disorder treatment from a Part 2 program. A testimonial does exactly what the rule forbids: it tells the world a named, pictured person was treated at your facility. That is a disclosure, and it needs Part 2 written consent that is specific, revocable, and informed about redisclosure, not a general photo release. The 2024 Final Rule sharpened that. No consent on file, no testimonial.
Records of the identity, diagnosis, prognosis, or treatment of any patient maintained in connection with a Part 2 program are confidential and may be disclosed only with written consent that meets the rule's requirements.
Clear Part 2 and the FTC endorsement rules, revised in 2023, still apply. An endorsement must reflect honest experience, disclose any material connection, and, the part that trips people up, convey the result a customer can generally expect. The old "results not typical" fine print is no longer a safe harbor. If a recovery story implies an outcome your data does not support, it is deceptive however sincerely it was given. Paid or incentivized testimonials add a disclosure duty on top.
An advertisement presenting endorsements by consumers is likely to convey that the endorser's experience is representative; the advertiser must possess substantiation for that generally expected performance.
Some states go further. New York is the sharp one: under Education Law 6530(27), a physician who uses a patient testimonial in advertising commits professional misconduct, a flat ban no matter how truthful or well-consented. Most states instead police testimonials through their deceptive-advertising and board rules.
| State | How it differs | Citation |
|---|---|---|
| New York | Facial ban on physician testimonials in advertising, professional misconduct. | N.Y. Educ. Law 6530(27)(a)(iii) |
| Florida | Testimonials policed through Board of Medicine advertising and deceptive-advertising rules. | Rule 64B8-11.001 F.A.C. |
| Most states | No flat ban; testimonials must clear the FTC and Part 2 layers and general consumer-protection law. | FTC Act; 42 CFR Part 2 |
The scanner does not decide whether you hold a Part 2 consent, it cannot see your files. It reads the copy for the claim a testimonial makes.
Here is a patient, three months sober, telling you why our center saved her life.
An identified patient testimonial in addiction marketing raises 42 CFR Part 2 consent questions and FTC endorsement-disclosure duties at once.
A staff member describes, in general terms, what the first week of the program looks like.
Conveys the experience without publishing an identified patient's protected relationship.
Sources
Pre-Trip is a rigorous screen, not legal advice. Counsel decides; we help you arrive prepared.